Is Ozempic a GLP-1?
FAQ-000043
Direct Answer
Yes, Ozempic is a GLP-1 medication. Its active ingredient is semaglutide, a GLP-1 receptor agonist, meaning it activates the same GLP-1 receptors in the body that the natural hormone GLP-1 does. Ozempic is FDA-approved for blood sugar control in type 2 diabetes, and also carries a cardiovascular risk reduction indication.
Why the Confusion Sometimes Comes Up
Ozempic and Wegovy contain the exact same active ingredient, semaglutide, but are marketed under different brand names because they're approved for different uses, Ozempic for diabetes, Wegovy for chronic weight management. Some people assume they must be different types of drugs because of the different names and different-looking packaging, but the core medication and mechanism are identical.
How This Fits the Broader GLP-1 Category
GLP-1 is a class of medications, not a single drug. Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), and several others all belong to this class, though some, like tirzepatide, also activate a second receptor (GIP) alongside GLP-1, making them dual agonists rather than single-target GLP-1 medications.
References
- Ozempic Prescribing Information (FDA)
Related Resources
Related Articles
Explore More
Explore the full GLP-1 Tracker knowledge base on DietApp.com
Get Started
Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 medication.
About DietApp.com
DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. The information on DietApp.com is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
is-ozempic-a-glp-1